JP2002501510A - ヒトにおける攪乱行動を改善し気分を高揚させる方法 - Google Patents
ヒトにおける攪乱行動を改善し気分を高揚させる方法Info
- Publication number
- JP2002501510A JP2002501510A JP54846498A JP54846498A JP2002501510A JP 2002501510 A JP2002501510 A JP 2002501510A JP 54846498 A JP54846498 A JP 54846498A JP 54846498 A JP54846498 A JP 54846498A JP 2002501510 A JP2002501510 A JP 2002501510A
- Authority
- JP
- Japan
- Prior art keywords
- dronabinol
- dementia
- patients
- administered
- behavior
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.痴呆症を患っているヒトを治療する方法であって、前記ヒトに治療有効量 のドロナビノールを投与することを含んでなる方法。 2.痴呆症がアルツハイマー型を含んでなる、請求項1の方法。 3.ドロナビノールが薬学的に有効な担体と組み合わせて投与される、請求項 1の方法。 4.精神活性医薬の投与を更に含んでなる、請求項1の方法。 5.精神活性医薬が、抗鬱薬、神経弛緩薬、及びベンゾジアゼピン類からなる 群から選択される、請求項4の方法。 6.ドロナビノールがヒトに経口投与される、請求項1の方法。 7.ドロナビノールが、一日当たり約0.03〜約0.06mg/kg体重の量 で投与される、請求項6の方法。 8.2.5mgのドロナビノールが一日当たり2回投与される、請求項6の方 法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4581397P | 1997-05-07 | 1997-05-07 | |
US08/866,511 US5804592A (en) | 1997-05-30 | 1997-05-30 | Method for improving disturbed behavior and elevating mood in humans |
US08/866,511 | 1997-05-30 | ||
US60/045,813 | 1997-05-30 | ||
PCT/US1998/009269 WO1998050027A1 (en) | 1997-05-07 | 1998-05-06 | Method of improving disturbed behavior and elevating mood in humans |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002501510A true JP2002501510A (ja) | 2002-01-15 |
JP2002501510A5 JP2002501510A5 (ja) | 2005-12-02 |
Family
ID=26723227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54846498A Ceased JP2002501510A (ja) | 1997-05-07 | 1998-05-06 | ヒトにおける攪乱行動を改善し気分を高揚させる方法 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1019041A4 (ja) |
JP (1) | JP2002501510A (ja) |
AU (1) | AU743788B2 (ja) |
CA (1) | CA2288693A1 (ja) |
IL (1) | IL132784A (ja) |
WO (1) | WO1998050027A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
WO2020212948A1 (en) | 2019-04-17 | 2020-10-22 | Compass Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521215A (en) * | 1989-11-07 | 1996-05-28 | Ramot University Authority For Applied Research And Industrial Development Ltd. | NMDA-blocking pharmaceuticals |
IL92238A (en) * | 1989-11-07 | 1995-07-31 | Yissum Res Dev Co | ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation |
US5596106A (en) * | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
-
1998
- 1998-05-06 CA CA002288693A patent/CA2288693A1/en not_active Abandoned
- 1998-05-06 IL IL13278498A patent/IL132784A/en not_active IP Right Cessation
- 1998-05-06 EP EP98920311A patent/EP1019041A4/en not_active Withdrawn
- 1998-05-06 WO PCT/US1998/009269 patent/WO1998050027A1/en not_active Application Discontinuation
- 1998-05-06 JP JP54846498A patent/JP2002501510A/ja not_active Ceased
- 1998-05-06 AU AU72916/98A patent/AU743788B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO1998050027A1 (en) | 1998-11-12 |
CA2288693A1 (en) | 1998-11-12 |
AU743788B2 (en) | 2002-02-07 |
AU7291698A (en) | 1998-11-27 |
EP1019041A4 (en) | 2002-04-17 |
EP1019041A1 (en) | 2000-07-19 |
IL132784A0 (en) | 2001-03-19 |
IL132784A (en) | 2004-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5804592A (en) | Method for improving disturbed behavior and elevating mood in humans | |
EP1793671B1 (en) | Use of memantine (namenda) to treat autism, compulsivity, and impulsivity | |
US8268892B2 (en) | Pharmaceutical formulations of modafinil | |
US20060252761A1 (en) | Augmentation of extinction via administration of sub-antimicrobial doses of D-cycloserine | |
AU2018342072B2 (en) | Use of fenfluramine formulation in reducing number and frequencies of convulsive seizures in patient populations | |
TWI549678B (zh) | 4-胺基吡啶於改善具有脫髓鞘及其他神經系統狀況之患者的神經認知及/或神經精神缺陷之用途 | |
CN110891558A (zh) | 使用芬氟拉明治疗多泽综合征的方法 | |
JP2008519847A (ja) | 運動障害の治療方法 | |
US11752111B2 (en) | Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders and schizophrenia | |
EP3930841A1 (en) | A formulation for improving seizure control | |
WO2018148380A1 (en) | Methods of treating seizure disorders and prader-willi syndrome | |
JP2002501510A (ja) | ヒトにおける攪乱行動を改善し気分を高揚させる方法 | |
US11660277B2 (en) | Use of (S)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders | |
US9682067B2 (en) | Methods of improving cognitive function | |
FR2542195A1 (fr) | Nouvelle association medicamenteuse | |
EP0834316B1 (fr) | Utilisation de la sulbutiamine pour l'obtention de compositions pharmaceutiques utiles dans le traitement de certains troubles psychomoteurs et psycho-intellectuels | |
WO2020018779A1 (en) | Use of phenylethylidenehydrazine to treat seizure disorders, developmental disorders, neurological disorders, behavioral disorders and addiction | |
JP2593910B2 (ja) | パニック障害の予防又は抑制剤 | |
MXPA99010187A (en) | Method of improving disturbed behavior and elevating mood in humans | |
RU2805061C2 (ru) | Лечение демиелинизирующих заболеваний | |
TW202131910A (zh) | 使用mtorc1調節劑的治療方法 | |
US20190201376A1 (en) | Method for Treating or Preventing Fatty Acid Binding Protein 3 Induced B-amyloid Aggregation Diseases | |
AU2011235981B2 (en) | Use of Memantine (Namenda) to Treat Autism, Compulsivity, and Impulsivity | |
WO2017207600A1 (en) | New treatment of sma | |
Pain et al. | 21 Medications That May Be Useful in the Management |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050506 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050506 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090317 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20090706 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090811 |